U.S. Physical Therapy, Inc. $USPH Stock Position Lessened by Boston Trust Walden Corp

Key Points

• Boston Trust Walden cut its U.S. Physical Therapy stake by 5.2%, selling 19,995 shares; it held 361,130 shares, worth about $31 million, at quarter-end.
• Quarterly results beat expectations: adjusted EPS was $0.80 versus $0.76 expected, while revenue rose 12.9% year over year to $222.56 million.
• Management reaffirmed full-year EBITDA guidance of $102 million to $106 million and declared a quarterly dividend of $0.46 per share.

Boston Trust Walden Corp reduced its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 5.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 361,130 shares of the company's stock after selling 19,995 shares during the period. Boston Trust Walden Corp owned about 2.42% of U.S. Physical Therapy worth $30,960,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of USPH. BlackRock Inc. purchased a new position in U.S. Physical Therapy in the 2nd quarter worth approximately $155,505,000. Copeland Capital Management LLC lifted its position in U.S. Physical Therapy by 11.8% during the third quarter. Copeland Capital Management LLC now owns 940,528 shares of the company's stock valued at $80,632,000 after buying an additional 98,984 shares during the period. Bank of America Corp DE lifted its position in U.S. Physical Therapy by 10.9% during the 1st quarter. Bank of America Corp DE now owns 554,621 shares of the company's stock valued at $41,574,000 after acquiring an additional 54,656 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of U.S. Physical Therapy by 3.2% during the first quarter. Dimensional Fund Advisors LP now owns 507,394 shares of the company's stock valued at $38,035,000 after purchasing an additional 15,668 shares during the last quarter. Finally, William Blair Investment Management LLC bought a new stake in U.S. Physical Therapy in the second quarter worth $30,013,000.

U.S. Physical Therapy News Summary

Here are the key news stories impacting U.S. Physical Therapy this week:

• Positive Sentiment: Q3 adjusted earnings were $0.80 per share, ahead of the $0.76 consensus and up from $0.66 a year earlier. Revenue rose 12.9% to $222.56 million, also exceeding estimates. The company cited record-high visits and revenue per visit. USPH Reports Third Quarter 2026 Results
• Positive Sentiment: Management reaffirmed its full-year EBITDA outlook of $102 million to $106 million. Hospital-related revenue also increased to more than 13%, providing another growth channel. USPH reaffirms full-year EBITDA guidance
• Positive Sentiment: The company declared a quarterly dividend of $0.46 per share, equivalent to $1.84 annually. The dividend is payable December 11 to shareholders of record November 16.

U.S. Physical Therapy Trading Up 8.8%

USPH opened at $97.05 on Friday. The firm has a market cap of $1.45 billion, a P/E ratio of -71.89, a P/E/G ratio of 2.27 and a beta of 1.16. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.48. The stock has a 50-day moving average of $83.78 and a 200 day moving average of $76.97. U.S. Physical Therapy, Inc. has a 12 month low of $58.19 and a 12 month high of $100.98.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.76 by $0.04. The company had revenue of $222.56 million for the quarter, compared to analyst estimates of $214.48 million. U.S. Physical Therapy had a return on equity of 10.00% and a net margin of 3.60%. U.S. Physical Therapy's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.66 EPS. As a group, research analysts forecast that U.S. Physical Therapy, Inc. will post 2.89 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 11th. Stockholders of record on Monday, November 16th will be paid a dividend of $0.46 per share. The ex-dividend date of this dividend is Monday, November 16th. This represents a $1.84 dividend on an annualized basis and a dividend yield of 1.9%. U.S. Physical Therapy's dividend payout ratio is currently 1,082.35%.

Wall Street Analysts Forecast Growth

USPH has been the topic of several recent analyst reports. Citigroup reissued a "market outperform" rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 19th. Barrington Research increased their target price on U.S. Physical Therapy from $90.00 to $98.00 and gave the company an "outperform" rating in a report on Monday, August 10th. JPMorgan Chase & Co. lifted their price target on shares of U.S. Physical Therapy from $90.00 to $95.00 and gave the stock an "overweight" rating in a research note on Friday, September 11th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 26th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $98.25.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc NYSE: USPH operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.

In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.